PL366316A1 - Hamowanie angiogenezy i wzrostu guza - Google Patents

Hamowanie angiogenezy i wzrostu guza

Info

Publication number
PL366316A1
PL366316A1 PL01366316A PL36631601A PL366316A1 PL 366316 A1 PL366316 A1 PL 366316A1 PL 01366316 A PL01366316 A PL 01366316A PL 36631601 A PL36631601 A PL 36631601A PL 366316 A1 PL366316 A1 PL 366316A1
Authority
PL
Poland
Prior art keywords
angiogenesis
inhibition
tumor growth
tumor
growth
Prior art date
Application number
PL01366316A
Other languages
English (en)
Other versions
PL205134B1 (pl
Inventor
Dale L. Boger
David A. Cheresh
Original Assignee
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Scripps Research Institute filed Critical The Scripps Research Institute
Publication of PL366316A1 publication Critical patent/PL366316A1/pl
Publication of PL205134B1 publication Critical patent/PL205134B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL366316A 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny PL205134B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27

Publications (2)

Publication Number Publication Date
PL366316A1 true PL366316A1 (pl) 2005-01-24
PL205134B1 PL205134B1 (pl) 2010-03-31

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
PL01358272A PL358272A1 (pl) 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza
PL366316A PL205134B1 (pl) 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL01358272A PL358272A1 (pl) 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza

Country Status (15)

Country Link
EP (2) EP1272173A4 (pl)
JP (2) JP2003528140A (pl)
KR (2) KR100767616B1 (pl)
CN (2) CN1245967C (pl)
AU (4) AU5101801A (pl)
CA (3) CA2659030A1 (pl)
CZ (2) CZ20023509A3 (pl)
HU (2) HUP0301797A3 (pl)
MX (2) MXPA02009504A (pl)
NO (2) NO20024576L (pl)
PL (2) PL358272A1 (pl)
RU (2) RU2276133C2 (pl)
SK (2) SK14852002A3 (pl)
WO (2) WO2001072297A1 (pl)
ZA (2) ZA200208628B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
KR100931784B1 (ko) 2003-10-23 2009-12-14 오츠카 세이야쿠 가부시키가이샤 방출조절성 멸균 아리피프라졸 주사제, 그 제조방법
RU2287341C1 (ru) * 2005-03-01 2006-11-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Ингибитор ангиогенеза, антиангиогенная фармацевтическая композиция на его основе и способ лечения злокачественных новообразований
LT2170279T (lt) 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
RU2404794C2 (ru) * 2008-11-27 2010-11-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Вагинальные суппозитории для лечения рака шейки матки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
CN1135717A (zh) * 1993-10-15 1996-11-13 罗纳-布朗克·罗莱尔药物有限公司 抗血栓形成的氮杂环烷基链烷酰肽和假肽
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
WO1998035231A1 (en) * 1997-02-07 1998-08-13 The Scripps Research Institute Convergent synthesis of combinatorial library
NZ506779A (en) * 1998-03-27 2003-08-29 Genentech Inc Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
PL358272A1 (pl) 2004-08-09
CZ20023509A3 (cs) 2003-06-18
HUP0301797A3 (en) 2010-09-28
CA2403871C (en) 2010-05-11
JP2003528850A (ja) 2003-09-30
AU5101801A (en) 2001-10-08
KR100767616B1 (ko) 2007-10-18
EP1272173A1 (en) 2003-01-08
NO20024578D0 (no) 2002-09-24
HUP0301797A2 (hu) 2003-09-29
AU2001249499B2 (en) 2005-04-21
KR20020091156A (ko) 2002-12-05
AU4949901A (en) 2001-10-08
KR100776185B1 (ko) 2007-11-16
KR20020084258A (ko) 2002-11-04
CZ20023510A3 (cs) 2003-03-12
JP2003528140A (ja) 2003-09-24
CA2659030A1 (en) 2001-10-04
EP1276713A4 (en) 2006-05-03
NO20024576D0 (no) 2002-09-24
SK14842002A3 (sk) 2003-04-01
CN1245967C (zh) 2006-03-22
ZA200208628B (en) 2004-02-12
CN1429106A (zh) 2003-07-09
CA2403630A1 (en) 2001-10-04
SK14852002A3 (sk) 2003-06-03
RU2002128751A (ru) 2004-03-10
CN1441777A (zh) 2003-09-10
PL205134B1 (pl) 2010-03-31
CA2403871A1 (en) 2001-10-04
CA2403630C (en) 2009-05-26
MXPA02009510A (es) 2003-05-21
RU2276133C2 (ru) 2006-05-10
NO328969B1 (no) 2010-06-28
CN1229339C (zh) 2005-11-30
NO20024578L (no) 2002-11-20
AU2001251018B2 (en) 2005-12-01
EP1276713A1 (en) 2003-01-22
WO2001072297A1 (en) 2001-10-04
WO2001072699A1 (en) 2001-10-04
NO20024576L (no) 2002-11-20
ZA200208626B (en) 2004-02-16
HUP0301621A3 (en) 2009-06-29
EP1272173A4 (en) 2006-05-03
RU2269339C2 (ru) 2006-02-10
HUP0301621A2 (hu) 2003-09-29
MXPA02009504A (es) 2003-05-21

Similar Documents

Publication Publication Date Title
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
AU2001296558A1 (en) Inhibitors of angiogenesis and tumor growth for local and systemic administration
AU2001256975A1 (en) Compositions and methods for inhibition of cancer invasion and angiogenesis
AU6147401A (en) Compositions and methods for the treatment of cancer
IL153379A0 (en) 3'-PRODRUGS OF 2'-DEOXY-beta-L-NUCLEOSIDES
AU2600800A (en) Promotion or inhibition of angiogenesis and cardiovascularization
AU2596700A (en) Promotion or inhibition of angiogenesis and cardiovascularization
EP1294949A4 (en) HUMAN TUMORNESCROSE FACTOR DELTA AND EPSILON
HUP0300873A3 (en) Stereoselective reduction of substituted oxo-butanes
AU5000001A (en) Treatment of vitiligo
HRP20020729A2 (en) Treatment of psoriasis
HUP0301797A3 (en) Inhibition of angiogenesis and tumor growth
AU9402401A (en) Treatment of cancers
AU2001296448A1 (en) Tumor marker and methods of use
IL141537A0 (en) Promotion or inhibition of angiogenesis and cardiovascularization
IL149281A0 (en) Treatment of cancer
AU1367202A (en) Manipulation of plant life cycles and/or growth phases
AU2001268670A1 (en) Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
EP1303281A4 (en) METHODS OF TREATMENT
HK1039129A (en) Novel inhibitors of angiogenesis and tumor growth
AU2001261031A1 (en) Inhibition of bone tumor formation using antisense cdna therapy
AU1310201A (en) Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen
TW477164U (en) Improved structure of flowerpot
IL142742A0 (en) Promotion or inhibition of angiogenesis and cardiovascularization
AU1747100A (en) Promotion or inhibition of angiogenesis and cardiovascularization

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110327